Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Head and Neck Neoplasms | 71 | 2024 | 2930 | 7.270 |
Why?
|
Tongue Neoplasms | 13 | 2023 | 185 | 6.930 |
Why?
|
Mouth Neoplasms | 23 | 2024 | 597 | 6.730 |
Why?
|
Carcinoma, Squamous Cell | 46 | 2024 | 4050 | 4.630 |
Why?
|
Otolaryngology | 17 | 2024 | 699 | 2.710 |
Why?
|
Tongue | 13 | 2023 | 406 | 2.700 |
Why?
|
Oropharyngeal Neoplasms | 11 | 2022 | 492 | 2.030 |
Why?
|
Papillomavirus Infections | 14 | 2022 | 1639 | 1.740 |
Why?
|
Lingual Nerve | 3 | 2019 | 31 | 1.700 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 8 | 2021 | 325 | 1.640 |
Why?
|
Glossectomy | 7 | 2023 | 60 | 1.510 |
Why?
|
Salivary Gland Neoplasms | 3 | 2020 | 306 | 1.490 |
Why?
|
Surgical Flaps | 16 | 2021 | 1680 | 1.350 |
Why?
|
Oral Surgical Procedures | 2 | 2021 | 172 | 1.200 |
Why?
|
Deglutition Disorders | 5 | 2023 | 640 | 1.090 |
Why?
|
Papillomaviridae | 7 | 2022 | 1139 | 0.970 |
Why?
|
Mouth | 4 | 2021 | 383 | 0.960 |
Why?
|
Hypoglossal Nerve | 2 | 2016 | 110 | 0.930 |
Why?
|
Free Tissue Flaps | 5 | 2024 | 335 | 0.920 |
Why?
|
Tracheal Stenosis | 2 | 2017 | 228 | 0.910 |
Why?
|
Ultrasonography | 7 | 2023 | 5990 | 0.830 |
Why?
|
Neck Dissection | 4 | 2019 | 201 | 0.800 |
Why?
|
Laryngeal Neoplasms | 4 | 2018 | 514 | 0.770 |
Why?
|
Cross Infection | 2 | 2020 | 1427 | 0.730 |
Why?
|
Larynx, Artificial | 2 | 2020 | 70 | 0.720 |
Why?
|
Neoplasm Staging | 16 | 2024 | 11218 | 0.720 |
Why?
|
Hematology | 1 | 2024 | 243 | 0.710 |
Why?
|
Alphapapillomavirus | 3 | 2022 | 219 | 0.710 |
Why?
|
Humans | 202 | 2024 | 766812 | 0.710 |
Why?
|
Laryngoplasty | 1 | 2020 | 53 | 0.700 |
Why?
|
Marital Status | 2 | 2019 | 426 | 0.690 |
Why?
|
Speech Disorders | 1 | 2021 | 178 | 0.680 |
Why?
|
Ranula | 1 | 2019 | 10 | 0.660 |
Why?
|
Papillomavirus Vaccines | 4 | 2022 | 497 | 0.650 |
Why?
|
Tracheostomy | 2 | 2020 | 430 | 0.640 |
Why?
|
Retrospective Studies | 61 | 2024 | 81657 | 0.640 |
Why?
|
Salivary Glands | 1 | 2020 | 231 | 0.630 |
Why?
|
Survivors | 4 | 2018 | 2379 | 0.630 |
Why?
|
Marketing of Health Services | 1 | 2020 | 151 | 0.630 |
Why?
|
Sexual Behavior | 3 | 2019 | 2193 | 0.630 |
Why?
|
Deglutition | 4 | 2023 | 208 | 0.620 |
Why?
|
Reimbursement, Incentive | 3 | 2020 | 541 | 0.620 |
Why?
|
Patient Care | 1 | 2024 | 629 | 0.610 |
Why?
|
Scalp | 4 | 2016 | 390 | 0.580 |
Why?
|
Cost Control | 1 | 2020 | 627 | 0.570 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 249 | 0.560 |
Why?
|
Insurance Coverage | 5 | 2020 | 1945 | 0.560 |
Why?
|
Patient Advocacy | 1 | 2019 | 361 | 0.550 |
Why?
|
Tracheotomy | 1 | 2018 | 174 | 0.550 |
Why?
|
State Government | 1 | 2020 | 388 | 0.550 |
Why?
|
Access to Information | 1 | 2020 | 317 | 0.550 |
Why?
|
SEER Program | 10 | 2022 | 1444 | 0.540 |
Why?
|
Medicare | 9 | 2023 | 6813 | 0.540 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2018 | 594 | 0.530 |
Why?
|
Mouth Mucosa | 2 | 2018 | 434 | 0.520 |
Why?
|
Lip | 3 | 2023 | 196 | 0.510 |
Why?
|
Orbit | 3 | 2006 | 459 | 0.500 |
Why?
|
Nose Neoplasms | 4 | 2021 | 250 | 0.500 |
Why?
|
Postoperative Complications | 10 | 2024 | 15831 | 0.490 |
Why?
|
Oropharynx | 1 | 2016 | 139 | 0.490 |
Why?
|
Analgesics, Opioid | 3 | 2021 | 3837 | 0.490 |
Why?
|
Cytodiagnosis | 1 | 2019 | 450 | 0.480 |
Why?
|
Temporal Bone | 5 | 2008 | 683 | 0.480 |
Why?
|
Male | 99 | 2024 | 364154 | 0.480 |
Why?
|
Middle Aged | 83 | 2024 | 223267 | 0.480 |
Why?
|
Aged | 69 | 2023 | 171344 | 0.470 |
Why?
|
Conflict of Interest | 1 | 2019 | 556 | 0.460 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2018 | 388 | 0.460 |
Why?
|
Salvage Therapy | 4 | 2021 | 1274 | 0.460 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3110 | 0.450 |
Why?
|
Mandible | 2 | 2014 | 747 | 0.450 |
Why?
|
Cross-Sectional Studies | 17 | 2023 | 26309 | 0.450 |
Why?
|
Quality of Life | 10 | 2023 | 13476 | 0.450 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3232 | 0.450 |
Why?
|
Health Status Disparities | 2 | 2015 | 1880 | 0.440 |
Why?
|
United States | 38 | 2024 | 72945 | 0.440 |
Why?
|
Biopsy, Fine-Needle | 1 | 2019 | 1131 | 0.440 |
Why?
|
Myoblasts | 2 | 2006 | 234 | 0.440 |
Why?
|
Surgery, Computer-Assisted | 1 | 2021 | 996 | 0.440 |
Why?
|
Laryngectomy | 6 | 2023 | 245 | 0.440 |
Why?
|
Pain, Postoperative | 2 | 2021 | 1768 | 0.440 |
Why?
|
Ambulatory Care Facilities | 1 | 2020 | 939 | 0.440 |
Why?
|
Female | 94 | 2024 | 396532 | 0.430 |
Why?
|
Neoplasms | 9 | 2024 | 22350 | 0.430 |
Why?
|
Drug Industry | 1 | 2019 | 791 | 0.420 |
Why?
|
Neoplasm Recurrence, Local | 11 | 2023 | 9407 | 0.410 |
Why?
|
Thyroid Cartilage | 4 | 2004 | 46 | 0.410 |
Why?
|
Medical Oncology | 1 | 2024 | 2340 | 0.400 |
Why?
|
Cause of Death | 3 | 2018 | 3717 | 0.390 |
Why?
|
Microsurgery | 3 | 2009 | 798 | 0.390 |
Why?
|
Ophthalmologic Surgical Procedures | 2 | 2006 | 354 | 0.390 |
Why?
|
Jugular Veins | 2 | 2021 | 211 | 0.380 |
Why?
|
Inpatients | 2 | 2022 | 2566 | 0.380 |
Why?
|
Craniotomy | 1 | 2016 | 736 | 0.370 |
Why?
|
Skull | 1 | 2016 | 819 | 0.370 |
Why?
|
Ear Neoplasms | 3 | 2008 | 118 | 0.370 |
Why?
|
Pandemics | 4 | 2023 | 8734 | 0.360 |
Why?
|
Medicaid | 4 | 2020 | 2836 | 0.360 |
Why?
|
Physician-Patient Relations | 1 | 2024 | 3266 | 0.360 |
Why?
|
Survival Analysis | 8 | 2018 | 10101 | 0.350 |
Why?
|
Awareness | 1 | 2015 | 653 | 0.350 |
Why?
|
Academic Medical Centers | 1 | 2021 | 2783 | 0.350 |
Why?
|
Neoplasm Invasiveness | 8 | 2023 | 3610 | 0.350 |
Why?
|
Life Expectancy | 1 | 2017 | 1248 | 0.350 |
Why?
|
Anemia | 2 | 2019 | 1514 | 0.350 |
Why?
|
Frozen Sections | 3 | 2020 | 153 | 0.340 |
Why?
|
Trachea | 2 | 2015 | 1094 | 0.340 |
Why?
|
Prognosis | 13 | 2023 | 29959 | 0.330 |
Why?
|
Neoplasms, Second Primary | 2 | 2018 | 1062 | 0.330 |
Why?
|
Disease-Free Survival | 8 | 2019 | 6853 | 0.320 |
Why?
|
Skull Base Neoplasms | 3 | 2008 | 280 | 0.320 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2022 | 4056 | 0.310 |
Why?
|
Preoperative Care | 1 | 2018 | 2253 | 0.310 |
Why?
|
Carcinoma, Adenoid Cystic | 5 | 2022 | 262 | 0.310 |
Why?
|
Facial Nerve | 2 | 2023 | 277 | 0.310 |
Why?
|
Adult | 54 | 2021 | 223305 | 0.310 |
Why?
|
Drug Prescriptions | 1 | 2018 | 1663 | 0.310 |
Why?
|
Surgical Wound Infection | 1 | 2018 | 1547 | 0.310 |
Why?
|
Pilot Projects | 5 | 2023 | 8728 | 0.300 |
Why?
|
Aged, 80 and over | 29 | 2022 | 59548 | 0.300 |
Why?
|
Paranasal Sinus Neoplasms | 4 | 2021 | 243 | 0.280 |
Why?
|
Societies, Medical | 1 | 2019 | 3957 | 0.280 |
Why?
|
Otorhinolaryngologic Diseases | 1 | 2008 | 97 | 0.280 |
Why?
|
Bone Marrow Cells | 1 | 2014 | 2413 | 0.280 |
Why?
|
Radiotherapy, Adjuvant | 7 | 2023 | 1788 | 0.270 |
Why?
|
Laryngostenosis | 2 | 2010 | 168 | 0.270 |
Why?
|
Stents | 2 | 2017 | 3193 | 0.270 |
Why?
|
Thyroid Neoplasms | 2 | 2018 | 2355 | 0.260 |
Why?
|
Opioid-Related Disorders | 1 | 2021 | 2188 | 0.260 |
Why?
|
Internship and Residency | 4 | 2022 | 5943 | 0.260 |
Why?
|
Speech | 2 | 2021 | 555 | 0.260 |
Why?
|
Patient Protection and Affordable Care Act | 3 | 2020 | 1188 | 0.260 |
Why?
|
Nasal Cavity | 4 | 2021 | 310 | 0.250 |
Why?
|
Skin Neoplasms | 5 | 2023 | 5860 | 0.240 |
Why?
|
Forearm | 5 | 2023 | 425 | 0.240 |
Why?
|
Sex Factors | 6 | 2019 | 10619 | 0.230 |
Why?
|
Orbital Diseases | 1 | 2006 | 178 | 0.230 |
Why?
|
Treatment Outcome | 19 | 2023 | 65286 | 0.230 |
Why?
|
Microcirculation | 1 | 2009 | 1282 | 0.230 |
Why?
|
Alcohol Drinking | 1 | 2017 | 4045 | 0.230 |
Why?
|
Orbit Evisceration | 1 | 2003 | 9 | 0.230 |
Why?
|
Sensation | 2 | 2023 | 331 | 0.220 |
Why?
|
Speech Intelligibility | 2 | 2023 | 80 | 0.220 |
Why?
|
Reimbursement Mechanisms | 2 | 2020 | 670 | 0.220 |
Why?
|
Intensive Care Units | 1 | 2017 | 3799 | 0.220 |
Why?
|
Coloring Agents | 2 | 2021 | 565 | 0.210 |
Why?
|
Rectus Abdominis | 1 | 2003 | 101 | 0.210 |
Why?
|
Carcinoma, Basal Cell | 5 | 2008 | 565 | 0.210 |
Why?
|
Laryngeal Diseases | 2 | 2020 | 248 | 0.210 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 3 | 2013 | 354 | 0.200 |
Why?
|
Depressive Disorder, Major | 2 | 2019 | 4810 | 0.200 |
Why?
|
Phonation | 2 | 2020 | 221 | 0.200 |
Why?
|
Bone Neoplasms | 1 | 2014 | 2561 | 0.200 |
Why?
|
Fistula | 3 | 2012 | 213 | 0.200 |
Why?
|
Esophageal Stenosis | 1 | 2023 | 196 | 0.200 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5367 | 0.200 |
Why?
|
Adenocarcinoma | 3 | 2018 | 6359 | 0.190 |
Why?
|
Rats, Wistar | 2 | 2016 | 1887 | 0.190 |
Why?
|
Fascia | 2 | 2000 | 143 | 0.190 |
Why?
|
Indocyanine Green | 1 | 2023 | 237 | 0.190 |
Why?
|
Facial Neoplasms | 2 | 2002 | 126 | 0.190 |
Why?
|
Communication | 1 | 2016 | 3905 | 0.190 |
Why?
|
Prostheses and Implants | 3 | 2000 | 1275 | 0.180 |
Why?
|
Logistic Models | 5 | 2020 | 13276 | 0.180 |
Why?
|
Reoperation | 4 | 2018 | 4325 | 0.180 |
Why?
|
Socioeconomic Factors | 4 | 2019 | 7841 | 0.180 |
Why?
|
Smoking | 2 | 2017 | 9077 | 0.180 |
Why?
|
Eye Diseases | 1 | 2006 | 660 | 0.180 |
Why?
|
Cricoid Cartilage | 2 | 2015 | 69 | 0.180 |
Why?
|
Cohort Studies | 12 | 2024 | 41706 | 0.180 |
Why?
|
Postoperative Care | 3 | 2020 | 1480 | 0.180 |
Why?
|
Intraoperative Period | 2 | 2021 | 512 | 0.180 |
Why?
|
Pharyngectomy | 1 | 2000 | 45 | 0.180 |
Why?
|
Parotid Neoplasms | 2 | 2019 | 158 | 0.180 |
Why?
|
Risk Assessment | 6 | 2021 | 24299 | 0.180 |
Why?
|
Endocrine Surgical Procedures | 1 | 2020 | 32 | 0.180 |
Why?
|
Preoperative Period | 2 | 2021 | 564 | 0.180 |
Why?
|
Relative Value Scales | 1 | 2020 | 85 | 0.170 |
Why?
|
Adenoviruses, Human | 2 | 2014 | 257 | 0.170 |
Why?
|
Neoplasm Metastasis | 4 | 2019 | 4892 | 0.170 |
Why?
|
Fee Schedules | 1 | 2020 | 86 | 0.170 |
Why?
|
Intubation | 1 | 2000 | 140 | 0.170 |
Why?
|
Positron-Emission Tomography | 2 | 2013 | 6548 | 0.170 |
Why?
|
Epistaxis | 1 | 2000 | 117 | 0.170 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2015 | 4652 | 0.160 |
Why?
|
Nose | 2 | 2020 | 522 | 0.160 |
Why?
|
Skull Neoplasms | 2 | 2007 | 173 | 0.160 |
Why?
|
Sphenoid Bone | 1 | 2000 | 176 | 0.160 |
Why?
|
Multivariate Analysis | 3 | 2018 | 12064 | 0.160 |
Why?
|
Insurance, Health | 4 | 2020 | 2520 | 0.160 |
Why?
|
Toll-Like Receptor 8 | 3 | 2014 | 98 | 0.160 |
Why?
|
Young Adult | 13 | 2021 | 59939 | 0.160 |
Why?
|
Prospective Payment System | 1 | 2020 | 134 | 0.160 |
Why?
|
Mandibular Neoplasms | 1 | 2000 | 131 | 0.160 |
Why?
|
Economics, Hospital | 1 | 2021 | 207 | 0.160 |
Why?
|
Illinois | 1 | 2019 | 120 | 0.160 |
Why?
|
Research Report | 1 | 2022 | 367 | 0.150 |
Why?
|
Tomography, X-Ray Computed | 6 | 2021 | 20710 | 0.150 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2019 | 91 | 0.150 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2015 | 1105 | 0.150 |
Why?
|
Prospective Studies | 9 | 2023 | 54872 | 0.150 |
Why?
|
Phototherapy | 1 | 2021 | 368 | 0.150 |
Why?
|
Managed Competition | 1 | 2018 | 33 | 0.150 |
Why?
|
Carotid Artery, Common | 2 | 2009 | 172 | 0.150 |
Why?
|
4-Nitroquinoline-1-oxide | 1 | 2017 | 17 | 0.150 |
Why?
|
Case-Control Studies | 6 | 2023 | 22248 | 0.150 |
Why?
|
Immune System Phenomena | 1 | 2017 | 17 | 0.150 |
Why?
|
Dissection | 2 | 2019 | 298 | 0.150 |
Why?
|
Momordica charantia | 1 | 2017 | 8 | 0.150 |
Why?
|
Regression Analysis | 3 | 2017 | 6329 | 0.150 |
Why?
|
CD4-Positive T-Lymphocytes | 4 | 2015 | 4410 | 0.150 |
Why?
|
Models, Educational | 1 | 2020 | 375 | 0.150 |
Why?
|
Nasal Mucosa | 1 | 2021 | 416 | 0.150 |
Why?
|
Surgical Wound Dehiscence | 1 | 2019 | 215 | 0.150 |
Why?
|
Skin Transplantation | 2 | 2000 | 1097 | 0.140 |
Why?
|
Arteries | 1 | 2022 | 1123 | 0.140 |
Why?
|
Hematocrit | 1 | 2019 | 622 | 0.140 |
Why?
|
Carotid Artery, Internal | 1 | 2000 | 440 | 0.140 |
Why?
|
Fluorescent Dyes | 2 | 2023 | 1927 | 0.140 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2020 | 392 | 0.140 |
Why?
|
Vocal Cord Paralysis | 3 | 2000 | 275 | 0.140 |
Why?
|
Medically Uninsured | 2 | 2020 | 838 | 0.140 |
Why?
|
Aerosols | 1 | 2020 | 634 | 0.140 |
Why?
|
Financing, Government | 1 | 2021 | 473 | 0.140 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2018 | 116 | 0.140 |
Why?
|
Specialties, Surgical | 1 | 2022 | 391 | 0.140 |
Why?
|
Cell Line, Tumor | 12 | 2024 | 17089 | 0.140 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2022 | 452 | 0.140 |
Why?
|
Regeneration | 1 | 2006 | 1520 | 0.140 |
Why?
|
Suicide | 2 | 2018 | 1606 | 0.140 |
Why?
|
Odds Ratio | 3 | 2019 | 9661 | 0.140 |
Why?
|
Survival Rate | 9 | 2021 | 12826 | 0.140 |
Why?
|
Cutaneous Fistula | 2 | 2012 | 79 | 0.140 |
Why?
|
Immunization Schedule | 1 | 2018 | 229 | 0.140 |
Why?
|
Adenoidectomy | 1 | 2018 | 171 | 0.140 |
Why?
|
Age Factors | 4 | 2018 | 18397 | 0.140 |
Why?
|
Face | 2 | 2002 | 1029 | 0.140 |
Why?
|
Physician Incentive Plans | 1 | 2018 | 165 | 0.140 |
Why?
|
Dentigerous Cyst | 1 | 1996 | 18 | 0.140 |
Why?
|
Maxillary Diseases | 1 | 1996 | 46 | 0.130 |
Why?
|
Plant Extracts | 2 | 2017 | 496 | 0.130 |
Why?
|
Esophagectomy | 1 | 2000 | 478 | 0.130 |
Why?
|
Liver Function Tests | 1 | 2018 | 527 | 0.130 |
Why?
|
Biopsy | 5 | 2024 | 6779 | 0.130 |
Why?
|
Blood Chemical Analysis | 1 | 2018 | 434 | 0.130 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2013 | 2028 | 0.130 |
Why?
|
Granuloma, Laryngeal | 1 | 1995 | 7 | 0.130 |
Why?
|
Tonsillar Neoplasms | 1 | 1996 | 49 | 0.130 |
Why?
|
Vaccination | 2 | 2018 | 3435 | 0.130 |
Why?
|
Adolescent | 19 | 2020 | 88902 | 0.130 |
Why?
|
Rats | 5 | 2016 | 23717 | 0.130 |
Why?
|
Mastication | 1 | 2015 | 53 | 0.130 |
Why?
|
Lymphatic Metastasis | 2 | 2022 | 2901 | 0.130 |
Why?
|
Kidney Function Tests | 1 | 2018 | 685 | 0.130 |
Why?
|
Neck Muscles | 1 | 2015 | 100 | 0.120 |
Why?
|
Reference Standards | 1 | 2019 | 1010 | 0.120 |
Why?
|
Paranasal Sinus Diseases | 2 | 2012 | 121 | 0.120 |
Why?
|
Granuloma, Foreign-Body | 1 | 1995 | 41 | 0.120 |
Why?
|
Databases, Factual | 5 | 2019 | 8065 | 0.120 |
Why?
|
Medicine | 1 | 2023 | 944 | 0.120 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2015 | 168 | 0.120 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 560 | 0.120 |
Why?
|
Tonsillectomy | 1 | 2018 | 281 | 0.120 |
Why?
|
Thigh | 1 | 2016 | 236 | 0.120 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2013 | 3114 | 0.120 |
Why?
|
Wrist | 1 | 1996 | 230 | 0.120 |
Why?
|
Office Visits | 1 | 2019 | 593 | 0.120 |
Why?
|
Rats, Inbred Lew | 3 | 2006 | 1168 | 0.120 |
Why?
|
Laryngeal Nerves | 1 | 1994 | 57 | 0.120 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2018 | 542 | 0.120 |
Why?
|
Pharyngeal Muscles | 1 | 1994 | 81 | 0.120 |
Why?
|
Polytetrafluoroethylene | 1 | 1995 | 242 | 0.110 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12536 | 0.110 |
Why?
|
Cucurbitaceae | 1 | 2013 | 2 | 0.110 |
Why?
|
Spiral Ganglion | 1 | 2015 | 180 | 0.110 |
Why?
|
Carotid Artery Diseases | 1 | 2000 | 872 | 0.110 |
Why?
|
Sexual Partners | 1 | 2019 | 804 | 0.110 |
Why?
|
Hospitals, University | 1 | 2015 | 572 | 0.110 |
Why?
|
Prosthesis Design | 1 | 2020 | 2120 | 0.110 |
Why?
|
Physicians | 2 | 2022 | 4591 | 0.110 |
Why?
|
Betapapillomavirus | 1 | 2013 | 15 | 0.110 |
Why?
|
Down-Regulation | 3 | 2018 | 2931 | 0.110 |
Why?
|
Hand Strength | 1 | 1996 | 466 | 0.110 |
Why?
|
Internationality | 1 | 2019 | 1006 | 0.110 |
Why?
|
Adenovirus E1A Proteins | 1 | 2013 | 81 | 0.110 |
Why?
|
Incidence | 4 | 2019 | 21527 | 0.110 |
Why?
|
Vascular Surgical Procedures | 1 | 2002 | 1506 | 0.110 |
Why?
|
Paralysis | 1 | 1994 | 250 | 0.110 |
Why?
|
Prevalence | 3 | 2019 | 15835 | 0.100 |
Why?
|
Independent Living | 1 | 2017 | 584 | 0.100 |
Why?
|
Parotid Gland | 3 | 2023 | 178 | 0.100 |
Why?
|
Neck | 4 | 2021 | 736 | 0.100 |
Why?
|
Lymphoma | 1 | 2002 | 1899 | 0.100 |
Why?
|
Cranial Irradiation | 1 | 2015 | 392 | 0.100 |
Why?
|
Chondroblastoma | 1 | 1992 | 47 | 0.100 |
Why?
|
Risk-Taking | 1 | 2018 | 1022 | 0.100 |
Why?
|
Bone Resorption | 1 | 1996 | 721 | 0.100 |
Why?
|
Delayed Diagnosis | 1 | 2015 | 454 | 0.100 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15425 | 0.100 |
Why?
|
Health Care Reform | 1 | 2021 | 1256 | 0.100 |
Why?
|
Tumor Microenvironment | 5 | 2017 | 3942 | 0.100 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1134 | 0.100 |
Why?
|
Healthcare Disparities | 2 | 2018 | 3411 | 0.090 |
Why?
|
Oncogene Proteins, Viral | 1 | 2013 | 342 | 0.090 |
Why?
|
Incidental Findings | 3 | 2011 | 698 | 0.090 |
Why?
|
Neurosurgical Procedures | 1 | 2002 | 2077 | 0.090 |
Why?
|
Oncolytic Virotherapy | 2 | 2014 | 520 | 0.090 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 3440 | 0.090 |
Why?
|
Animals | 19 | 2024 | 168939 | 0.090 |
Why?
|
Motivation | 1 | 2020 | 2020 | 0.090 |
Why?
|
Coculture Techniques | 4 | 2018 | 1337 | 0.090 |
Why?
|
Transcription Factors | 2 | 2022 | 12159 | 0.090 |
Why?
|
Intracranial Aneurysm | 1 | 2000 | 1271 | 0.090 |
Why?
|
Fluorescence | 2 | 2023 | 751 | 0.090 |
Why?
|
Time Factors | 5 | 2021 | 40149 | 0.090 |
Why?
|
Tissue Engineering | 3 | 2006 | 1857 | 0.090 |
Why?
|
Combined Modality Therapy | 4 | 2021 | 8540 | 0.090 |
Why?
|
Mice, SCID | 4 | 2017 | 2626 | 0.080 |
Why?
|
Cannabis | 1 | 2016 | 447 | 0.080 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2013 | 617 | 0.080 |
Why?
|
Hospitalization | 2 | 2020 | 10816 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2013 | 562 | 0.080 |
Why?
|
Registries | 3 | 2020 | 8352 | 0.080 |
Why?
|
Anastomosis, Surgical | 2 | 2021 | 992 | 0.080 |
Why?
|
Students, Medical | 1 | 2022 | 1962 | 0.080 |
Why?
|
Length of Stay | 2 | 2021 | 6491 | 0.080 |
Why?
|
Risk | 2 | 2020 | 9602 | 0.080 |
Why?
|
Health Expenditures | 2 | 2019 | 2389 | 0.080 |
Why?
|
Cochlea | 1 | 2015 | 848 | 0.080 |
Why?
|
Disease Models, Animal | 3 | 2017 | 18329 | 0.080 |
Why?
|
Education, Medical, Graduate | 1 | 2021 | 2418 | 0.080 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2020 | 3552 | 0.080 |
Why?
|
Constriction, Pathologic | 2 | 2023 | 1104 | 0.080 |
Why?
|
Risk Factors | 10 | 2020 | 74889 | 0.080 |
Why?
|
Cadaver | 3 | 2020 | 1362 | 0.080 |
Why?
|
Ear Auricle | 1 | 2008 | 31 | 0.080 |
Why?
|
Missouri | 1 | 2008 | 113 | 0.080 |
Why?
|
T-Lymphocyte Subsets | 2 | 2015 | 1814 | 0.070 |
Why?
|
Hodgkin Disease | 1 | 1996 | 1384 | 0.070 |
Why?
|
Patient Discharge | 1 | 2021 | 3466 | 0.070 |
Why?
|
Adaptive Immunity | 1 | 2013 | 734 | 0.070 |
Why?
|
Subclavian Artery | 1 | 2008 | 138 | 0.070 |
Why?
|
DNA, Viral | 3 | 2022 | 2201 | 0.070 |
Why?
|
Activities of Daily Living | 1 | 2017 | 2429 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2022 | 5795 | 0.070 |
Why?
|
Pneumonia | 1 | 2019 | 2161 | 0.070 |
Why?
|
Follow-Up Studies | 8 | 2019 | 39312 | 0.070 |
Why?
|
Radiotherapy | 4 | 2021 | 1497 | 0.070 |
Why?
|
Maxillary Sinus | 2 | 2000 | 172 | 0.070 |
Why?
|
Neoplastic Stem Cells | 1 | 2015 | 1349 | 0.070 |
Why?
|
Cell Proliferation | 5 | 2024 | 10451 | 0.070 |
Why?
|
Multiprotein Complexes | 1 | 2013 | 1110 | 0.070 |
Why?
|
Feasibility Studies | 1 | 2017 | 5306 | 0.070 |
Why?
|
Nursing Staff, Hospital | 1 | 2009 | 350 | 0.060 |
Why?
|
Breast Neoplasms | 4 | 2015 | 21162 | 0.060 |
Why?
|
Lymphoma, T-Cell | 1 | 2008 | 308 | 0.060 |
Why?
|
Carbon | 2 | 2006 | 672 | 0.060 |
Why?
|
Mice, Inbred NOD | 3 | 2015 | 1836 | 0.060 |
Why?
|
MAP Kinase Signaling System | 1 | 2012 | 1492 | 0.060 |
Why?
|
Telemedicine | 1 | 2023 | 3111 | 0.060 |
Why?
|
Quality Improvement | 1 | 2020 | 3850 | 0.060 |
Why?
|
Treatment Failure | 1 | 2011 | 2659 | 0.060 |
Why?
|
Ear, External | 3 | 2007 | 165 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3459 | 0.060 |
Why?
|
Head | 2 | 2005 | 926 | 0.060 |
Why?
|
Critical Care | 1 | 2017 | 2714 | 0.060 |
Why?
|
Mice | 11 | 2024 | 81898 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3230 | 0.060 |
Why?
|
Mice, Nude | 2 | 2024 | 3618 | 0.060 |
Why?
|
Melanoma | 3 | 2021 | 5702 | 0.060 |
Why?
|
Immunity, Innate | 2 | 2013 | 3079 | 0.050 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2019 | 754 | 0.050 |
Why?
|
Radiotherapy Dosage | 3 | 2018 | 2916 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2013 | 2841 | 0.050 |
Why?
|
Depression | 2 | 2023 | 8225 | 0.050 |
Why?
|
Hematoma | 2 | 2005 | 766 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 1405 | 0.050 |
Why?
|
Smiling | 1 | 2023 | 71 | 0.050 |
Why?
|
Facial Muscles | 1 | 2023 | 159 | 0.050 |
Why?
|
Dilatation | 1 | 2023 | 311 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5513 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2009 | 1794 | 0.050 |
Why?
|
Dendritic Cells | 1 | 2013 | 2747 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2014 | 3605 | 0.050 |
Why?
|
Apoptosis | 4 | 2024 | 9514 | 0.050 |
Why?
|
Fibula | 1 | 2024 | 270 | 0.050 |
Why?
|
Orbital Neoplasms | 1 | 2003 | 223 | 0.050 |
Why?
|
Decompression, Surgical | 1 | 2006 | 603 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2013 | 14653 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2015 | 3235 | 0.050 |
Why?
|
Saphenous Vein | 1 | 2004 | 519 | 0.050 |
Why?
|
Weight-Bearing | 1 | 2024 | 530 | 0.050 |
Why?
|
Educational Status | 2 | 2019 | 2510 | 0.050 |
Why?
|
Titanium | 1 | 2004 | 494 | 0.050 |
Why?
|
Immunohistochemistry | 4 | 2019 | 11062 | 0.050 |
Why?
|
Signal Transduction | 4 | 2024 | 23618 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20146 | 0.050 |
Why?
|
Graft Survival | 2 | 2005 | 3904 | 0.050 |
Why?
|
Speech, Esophageal | 1 | 2000 | 11 | 0.050 |
Why?
|
Endoscopy | 2 | 2021 | 1854 | 0.040 |
Why?
|
Rhabdomyosarcoma | 1 | 2003 | 358 | 0.040 |
Why?
|
Glycolysis | 1 | 2024 | 837 | 0.040 |
Why?
|
Hypopharynx | 1 | 2000 | 53 | 0.040 |
Why?
|
Cell Movement | 1 | 2012 | 5204 | 0.040 |
Why?
|
Child | 6 | 2017 | 80670 | 0.040 |
Why?
|
Metabolic Networks and Pathways | 1 | 2024 | 800 | 0.040 |
Why?
|
Cell Survival | 2 | 2009 | 5749 | 0.040 |
Why?
|
Radius | 1 | 2023 | 441 | 0.040 |
Why?
|
Mucocele | 1 | 2000 | 51 | 0.040 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2003 | 553 | 0.040 |
Why?
|
Carcinoma in Situ | 1 | 2005 | 784 | 0.040 |
Why?
|
Epidermal Cyst | 1 | 2000 | 63 | 0.040 |
Why?
|
Comorbidity | 3 | 2019 | 10580 | 0.040 |
Why?
|
Linear Models | 2 | 2019 | 5873 | 0.040 |
Why?
|
Killer Cells, Natural | 1 | 2008 | 2209 | 0.040 |
Why?
|
Pharyngeal Diseases | 1 | 2000 | 134 | 0.040 |
Why?
|
Palate, Soft | 1 | 2019 | 100 | 0.040 |
Why?
|
Carcinoma | 3 | 2012 | 2325 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2017 | 18986 | 0.040 |
Why?
|
Adenolymphoma | 1 | 1999 | 11 | 0.040 |
Why?
|
Hyperplasia | 1 | 2022 | 1150 | 0.040 |
Why?
|
Random Allocation | 1 | 2003 | 2394 | 0.040 |
Why?
|
Orbital Fractures | 1 | 2000 | 108 | 0.040 |
Why?
|
Angiography, Digital Subtraction | 1 | 2000 | 331 | 0.040 |
Why?
|
Suture Techniques | 1 | 2004 | 775 | 0.040 |
Why?
|
Transplantation, Autologous | 1 | 2004 | 2127 | 0.040 |
Why?
|
Radial Artery | 1 | 2000 | 187 | 0.040 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2011 | 2186 | 0.040 |
Why?
|
Arkansas | 1 | 2018 | 59 | 0.040 |
Why?
|
Eye, Artificial | 1 | 1998 | 18 | 0.040 |
Why?
|
Cultural Diversity | 1 | 2022 | 370 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2019 | 11514 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 10384 | 0.040 |
Why?
|
Poverty | 2 | 2020 | 2714 | 0.040 |
Why?
|
Heparin | 1 | 2005 | 1636 | 0.040 |
Why?
|
Chordoma | 1 | 2001 | 349 | 0.040 |
Why?
|
Chronic Disease | 3 | 2004 | 9358 | 0.040 |
Why?
|
Tumor Cells, Cultured | 2 | 2017 | 6105 | 0.040 |
Why?
|
Gastrostomy | 1 | 2000 | 325 | 0.040 |
Why?
|
History, 21st Century | 1 | 2004 | 1574 | 0.040 |
Why?
|
Intraoperative Complications | 1 | 2004 | 1171 | 0.040 |
Why?
|
Hemoglobin A | 1 | 1997 | 84 | 0.030 |
Why?
|
Photosensitizing Agents | 1 | 2021 | 627 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2014 | 10263 | 0.030 |
Why?
|
Oncogenes | 1 | 2022 | 1232 | 0.030 |
Why?
|
Oroantral Fistula | 1 | 1996 | 7 | 0.030 |
Why?
|
Patient Compliance | 2 | 2018 | 2694 | 0.030 |
Why?
|
Oral Hemorrhage | 1 | 1996 | 24 | 0.030 |
Why?
|
Medically Underserved Area | 1 | 2019 | 268 | 0.030 |
Why?
|
Osseointegration | 1 | 1998 | 271 | 0.030 |
Why?
|
Blotting, Western | 2 | 2014 | 5022 | 0.030 |
Why?
|
Esthetics | 1 | 1998 | 328 | 0.030 |
Why?
|
Mediastinitis | 1 | 1996 | 49 | 0.030 |
Why?
|
Karnofsky Performance Status | 1 | 2016 | 163 | 0.030 |
Why?
|
Particle Size | 1 | 2020 | 1633 | 0.030 |
Why?
|
Intubation, Intratracheal | 1 | 2004 | 1359 | 0.030 |
Why?
|
History, 20th Century | 1 | 2004 | 2764 | 0.030 |
Why?
|
Lymphatic Irradiation | 1 | 2016 | 115 | 0.030 |
Why?
|
Pemphigoid, Benign Mucous Membrane | 1 | 1996 | 113 | 0.030 |
Why?
|
Radiation Injuries | 2 | 2016 | 1195 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2005 | 2078 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2015 | 6225 | 0.030 |
Why?
|
Immunization Programs | 1 | 2018 | 267 | 0.030 |
Why?
|
Carcinogens | 1 | 2017 | 452 | 0.030 |
Why?
|
Cell Communication | 2 | 2013 | 1660 | 0.030 |
Why?
|
Speech, Alaryngeal | 1 | 1995 | 32 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15912 | 0.030 |
Why?
|
Radiation Injuries, Experimental | 1 | 2015 | 88 | 0.030 |
Why?
|
Tomography, Emission-Computed | 1 | 1997 | 1006 | 0.030 |
Why?
|
Cerebral Angiography | 1 | 2000 | 1263 | 0.030 |
Why?
|
Thyroidectomy | 1 | 2020 | 912 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2039 | 0.030 |
Why?
|
Adenovirus E1B Proteins | 1 | 2014 | 15 | 0.030 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2014 | 89 | 0.030 |
Why?
|
Cell Cycle | 2 | 2013 | 2925 | 0.030 |
Why?
|
9,10-Dimethyl-1,2-benzanthracene | 1 | 2014 | 58 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2012 | 2952 | 0.030 |
Why?
|
Endocrinology | 1 | 2020 | 441 | 0.030 |
Why?
|
Veins | 1 | 1999 | 769 | 0.030 |
Why?
|
Injections, Intralesional | 1 | 1995 | 280 | 0.030 |
Why?
|
Relative Biological Effectiveness | 1 | 2016 | 313 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2015 | 5890 | 0.030 |
Why?
|
Kinetics | 1 | 2022 | 6288 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2018 | 2012 | 0.030 |
Why?
|
Mesocricetus | 1 | 2014 | 256 | 0.030 |
Why?
|
Enteral Nutrition | 1 | 2000 | 802 | 0.030 |
Why?
|
Cranial Nerve Diseases | 1 | 1994 | 111 | 0.030 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 1 | 2015 | 256 | 0.030 |
Why?
|
Medical Illustration | 1 | 1994 | 134 | 0.030 |
Why?
|
Cleft Palate | 1 | 2019 | 596 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 1999 | 1615 | 0.030 |
Why?
|
Auditory Threshold | 1 | 2015 | 369 | 0.030 |
Why?
|
Mice, Knockout | 3 | 2014 | 14473 | 0.030 |
Why?
|
Eating | 1 | 2000 | 1539 | 0.030 |
Why?
|
Cranial Fossa, Posterior | 2 | 2006 | 134 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1596 | 0.030 |
Why?
|
Aspirin | 1 | 2005 | 3134 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2001 | 3796 | 0.030 |
Why?
|
Bone Transplantation | 1 | 1998 | 921 | 0.030 |
Why?
|
Sequence Homology | 1 | 2013 | 197 | 0.030 |
Why?
|
Ultrasonography, Interventional | 1 | 2021 | 1521 | 0.030 |
Why?
|
Marijuana Smoking | 1 | 2016 | 261 | 0.030 |
Why?
|
Postoperative Period | 1 | 2018 | 1824 | 0.030 |
Why?
|
Travel | 1 | 2019 | 806 | 0.030 |
Why?
|
Universities | 1 | 2018 | 1004 | 0.030 |
Why?
|
Prosthesis Failure | 1 | 1998 | 1208 | 0.030 |
Why?
|
Erythropoietin | 1 | 1997 | 718 | 0.030 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2018 | 798 | 0.030 |
Why?
|
Wound Healing | 1 | 2003 | 2800 | 0.030 |
Why?
|
Neuroectodermal Tumors | 1 | 2012 | 23 | 0.030 |
Why?
|
Genetic Vectors | 2 | 2014 | 3401 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1994 | 1622 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2015 | 582 | 0.020 |
Why?
|
Marijuana Abuse | 1 | 2016 | 409 | 0.020 |
Why?
|
Erythrocyte Transfusion | 1 | 1997 | 574 | 0.020 |
Why?
|
Caspase 3 | 1 | 2014 | 730 | 0.020 |
Why?
|
Pharynx | 1 | 1994 | 436 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2012 | 11876 | 0.020 |
Why?
|
Drug Costs | 1 | 2020 | 1194 | 0.020 |
Why?
|
Receptor, Notch1 | 1 | 2015 | 518 | 0.020 |
Why?
|
Immunotherapy | 2 | 2021 | 4747 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2015 | 559 | 0.020 |
Why?
|
Income | 1 | 2020 | 1876 | 0.020 |
Why?
|
Airway Obstruction | 1 | 1996 | 672 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 376 | 0.020 |
Why?
|
Thrombosis | 1 | 2005 | 2953 | 0.020 |
Why?
|
Nasal Cartilages | 1 | 2010 | 16 | 0.020 |
Why?
|
Voice Disorders | 1 | 1994 | 286 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2013 | 874 | 0.020 |
Why?
|
Up-Regulation | 2 | 2015 | 4143 | 0.020 |
Why?
|
Etoposide | 1 | 2012 | 638 | 0.020 |
Why?
|
Cyclic AMP | 1 | 2014 | 1472 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2980 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3885 | 0.020 |
Why?
|
Gene Expression | 2 | 2013 | 7585 | 0.020 |
Why?
|
Necrosis | 2 | 2009 | 1614 | 0.020 |
Why?
|
Range of Motion, Articular | 1 | 1996 | 1597 | 0.020 |
Why?
|
Suicide, Attempted | 1 | 2018 | 1413 | 0.020 |
Why?
|
Intraoperative Care | 1 | 1993 | 768 | 0.020 |
Why?
|
Anticoagulants | 1 | 2005 | 4854 | 0.020 |
Why?
|
Paranasal Sinuses | 1 | 2012 | 267 | 0.020 |
Why?
|
Qualitative Research | 1 | 2020 | 3138 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2019 | 2116 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 705 | 0.020 |
Why?
|
Health Care Costs | 1 | 2022 | 3240 | 0.020 |
Why?
|
Ligation | 1 | 2009 | 446 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3915 | 0.020 |
Why?
|
Medication Adherence | 1 | 2020 | 2190 | 0.020 |
Why?
|
Students | 1 | 2018 | 1741 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2017 | 22351 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 1997 | 2703 | 0.020 |
Why?
|
Recurrence | 2 | 2000 | 8507 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2009 | 412 | 0.020 |
Why?
|
Dental Implants | 1 | 1996 | 790 | 0.020 |
Why?
|
Bone and Bones | 1 | 1998 | 2559 | 0.020 |
Why?
|
Glycoproteins | 1 | 2015 | 2201 | 0.020 |
Why?
|
Ear Canal | 1 | 2007 | 149 | 0.020 |
Why?
|
Neutrons | 1 | 2006 | 78 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2015 | 2391 | 0.020 |
Why?
|
Sphenoid Sinus | 1 | 2006 | 101 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2017 | 2535 | 0.020 |
Why?
|
Polymers | 1 | 1993 | 1624 | 0.020 |
Why?
|
RNA Interference | 1 | 2014 | 2829 | 0.020 |
Why?
|
Neurosurgery | 1 | 1992 | 682 | 0.020 |
Why?
|
Cisplatin | 1 | 2012 | 1656 | 0.020 |
Why?
|
Cavernous Sinus | 1 | 2006 | 121 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2015 | 2429 | 0.020 |
Why?
|
Ear, Middle | 1 | 2007 | 341 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 13644 | 0.020 |
Why?
|
Equipment Design | 1 | 1993 | 3488 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 1996 | 2662 | 0.020 |
Why?
|
Virus Replication | 1 | 2013 | 2457 | 0.020 |
Why?
|
Mass Screening | 1 | 2020 | 5454 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6514 | 0.010 |
Why?
|
Immunotherapy, Adoptive | 1 | 2014 | 1503 | 0.010 |
Why?
|
Carboplatin | 2 | 1997 | 790 | 0.010 |
Why?
|
Skin | 1 | 1998 | 4499 | 0.010 |
Why?
|
Antigens, CD | 1 | 2015 | 4033 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 1994 | 1659 | 0.010 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2006 | 289 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2013 | 2426 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 2005 | 684 | 0.010 |
Why?
|
Myofibrils | 1 | 2003 | 143 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 1998 | 4968 | 0.010 |
Why?
|
Peptides | 1 | 2015 | 4347 | 0.010 |
Why?
|
Remission Induction | 1 | 2008 | 2413 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2013 | 2902 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8623 | 0.010 |
Why?
|
Cathepsin L | 1 | 2001 | 69 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9528 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2013 | 13411 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2012 | 5502 | 0.010 |
Why?
|
Protons | 1 | 2006 | 1101 | 0.010 |
Why?
|
Collagenases | 1 | 2001 | 221 | 0.010 |
Why?
|
Sarcoma | 1 | 2012 | 1802 | 0.010 |
Why?
|
Cathepsins | 1 | 2001 | 243 | 0.010 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2001 | 324 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 17609 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2012 | 3600 | 0.010 |
Why?
|
Paclitaxel | 2 | 1997 | 1728 | 0.010 |
Why?
|
Staining and Labeling | 1 | 2003 | 1075 | 0.010 |
Why?
|
Dura Mater | 1 | 2001 | 292 | 0.010 |
Why?
|
Cysteine Endopeptidases | 1 | 2001 | 542 | 0.010 |
Why?
|
Glottis | 1 | 2000 | 214 | 0.010 |
Why?
|
Base Sequence | 1 | 2009 | 12415 | 0.010 |
Why?
|
Multigene Family | 1 | 2001 | 1081 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2001 | 1989 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13642 | 0.010 |
Why?
|
Voice Quality | 1 | 2000 | 226 | 0.010 |
Why?
|
Hair | 1 | 2001 | 508 | 0.010 |
Why?
|
Algorithms | 1 | 1998 | 14073 | 0.010 |
Why?
|
Cytokines | 1 | 2012 | 7438 | 0.010 |
Why?
|
Alopecia | 1 | 2001 | 416 | 0.010 |
Why?
|
Child, Preschool | 2 | 2005 | 42577 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1996 | 425 | 0.010 |
Why?
|
Osteosarcoma | 1 | 2001 | 908 | 0.010 |
Why?
|
Azathioprine | 1 | 1996 | 354 | 0.010 |
Why?
|
Sampling Studies | 1 | 1996 | 614 | 0.010 |
Why?
|
Laryngoscopy | 1 | 2000 | 714 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 4570 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2009 | 5330 | 0.010 |
Why?
|
Neoplasm, Residual | 1 | 1997 | 1012 | 0.010 |
Why?
|
Prednisone | 1 | 1996 | 1566 | 0.010 |
Why?
|
Thoracic Neoplasms | 1 | 1993 | 269 | 0.010 |
Why?
|
Mutation | 2 | 2009 | 30214 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 1997 | 4853 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2001 | 3698 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2000 | 3485 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1997 | 6507 | 0.000 |
Why?
|
Software | 1 | 2001 | 4464 | 0.000 |
Why?
|
Glucocorticoids | 1 | 1996 | 2158 | 0.000 |
Why?
|
Anti-Inflammatory Agents | 1 | 1996 | 1805 | 0.000 |
Why?
|
Models, Biological | 1 | 2001 | 9464 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 1992 | 36570 | 0.000 |
Why?
|
Life Style | 1 | 1996 | 3926 | 0.000 |
Why?
|
Immunoglobulin G | 1 | 1996 | 4559 | 0.000 |
Why?
|
Immunosuppressive Agents | 1 | 1996 | 4215 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1996 | 12985 | 0.000 |
Why?
|